LIFE Stock Price History and Quote Analysis: Insights for Investors

A company's 13F filings with the Securities and Exchange Commission (SEC) provides investors with comprehensive information about institutional ownership in a listed company, a sign of strength in terms of how many institutions have confidence in that company. The number of institutional investors who currently own LIFE shares is 67, representing 61.69% of the company's common stock.

TWO SIGMA ADVISERS, LP, in the last quarter, reduced its stake in LIFE by -3.65% restricting it's holding to 142.35 thousand shares of worth nearly $277.58K. ROYAL BANK OF CANADA also lessened -83% of the LIFE shares from its portfolio, reducing its holding to 15.52 thousand shares of worth $30.00K. CUBIST SYSTEMATIC STRATEGIES, LLC also shunned LIFE shares holding by -33.27% last quarter which brought its holding to 11.74 thousand shares worth $22.89K.

As per its latest 13F filing, AMERICAN CENTURY COMPANIES INC increased its stake in LIFE by 144.76% in the last quarter. The institutional holder raised its holding to 54.04 thousand shares having worth more than $105.38K. JUMP FINANCIAL, LLC also added 100% more shares of LIFE to its portfolio, raising its holding to 49.9 thousand shares of worth $97.31K. ACADIAN ASSET MANAGEMENT LLC also increased its LIFE shares holding by 119.56% which brought its holding to 45.37 thousand shares worth $87.00K.

The insider with the most stakes in LIFE is Sofinnova Venture Partners IX, L.P. , 10 percent owner at the company. Additionally, LIFE stock is highly held by director AKKARAJU SRINIVAS and director MENDLEIN JOHN among others.

Company executives, directors, and other insiders own 2.62% percent of aTyr Pharma, Inc.'s stock. Within the last six months, there have been 0 transaction(s) in which LIFE insiders have sold stock, totaling 0 shares. Insiders that have sold shares include BROADFOOT JILL MARIE, CLARKE JOHN K, and SHUKLA SANJAY.

There have been 3 transaction(s) during the past 6-months in which aTyr Pharma, Inc. insiders have bought stock, totalling 75000 shares

Around 220.51K aTyr Pharma, Inc. shares are held by insiders, which represents about 2.62% of LIFE stock.

LIFE 10 percent owner, Sofinnova Venture Partners IX, L.P. holds the largest portfolio of the company's shares. LIFE shares owned by Sofinnova total nearly 1.87 million.

AMERICAN CENTURY COMPANIES INC is the largest institutional owner in LIFE which holds 54.04 thousand shares worth $105.38K or 0.1% of the total LIFE shares outstanding followed by JUMP FINANCIAL, LLC with ownership of 49.9 thousand shares representing 0.09% of the LIFE ownership. ACADIAN ASSET MANAGEMENT LLC is the third largest stakeholder with 45.37 thousand shares or 0.08% of the ownership worth more than $87.00K.

Stock options give the owner the ability but not the obligation to buy or sell a security at a predetermined price and date. Stock options can be classified into two types: puts and calls. A put is a bet on falling stock, and a call is a bet on rising stock. As far as the LIFE is concerned, it is a stock which is not optionable.

Number of LIFE shares short is 343.41K. Shares short is a market sentiment in which investors have sold their shares short in a given stock but have not yet covered them or closed them out.

As of today, 69.01M shares of LIFE are outstanding.

Float represents the number of tradeable shares in a specific stock. By subtracting restricted and closely-held shares from a firm's total outstanding shares, we can calculate its floating stock. The term "closely-held shares" refers to shares held by employees, major shareholders, and company insiders. At present, LIFE has 67.12M shares in float.

Short ratio is calculated by dividing the number of short shares, short interest or bets that shareholders will sell short from the average daily volume. A higher ratio indicates longer times needed to repurchase borrowed shares (sold). The short ratio for LIFE is 0.6.